Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer

ObjectivesTo compare the efficacy and safety of three drugs—Apalutamide, Abiraterone, and Bicalutamide—combined with Androgen Deprivation Therapy (ADT) in patients with metastatic hormone-sensitive prostate cancer (mHSPC).MethodsWe retrospectively collected survival data of patients treated at our h...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Jiabin Zhang, Qiang Wang, Junjie Zhou, Huiyu Gao, Peng Hao, Tao Wu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-10-01
Subjects:	apalutamide abiraterone acetate bicalutamide prostate cancer endocrine therapy androgen deprivation therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1656216/full